MRC1 and neoplasm: For subgroup analyses by tumor localization (colon vs. rectum) and MMR status (proficient vs. deficient), we only regarded as noteworthy those findings that showed a test of heterogeneity with P < 0.05, and subgroup tests for trend <0.002.